European Infection Control Market - Forecast To 2030
商品番号 : SMB-85991
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 477 |
| 図表数 | 515 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、製品・サービス、エンドユーザー、そして国別に、欧州の感染管理市場を分析しています。また、市場成長に影響を与える要因(推進要因、制約要因、機会、課題など)を分析するとともに、市場リーダーの競争環境の詳細も提供しています。さらに、ミクロ市場の成長傾向を分析し、13カ国における市場セグメントの収益予測も提供しています。
本レポートは、既存企業だけでなく新規参入企業や小規模企業も市場の動向を把握し、市場シェアの拡大に役立てることができます。本レポートを購入した企業は、以下に示す戦略のいずれか、または組み合わせて活用することで、市場でのプレゼンスを強化することができます。
欧州の感染制御市場は、予測期間中に6.6%のCAGRで成長し、2025年の149億9,000万米ドルから2030年には205億8,000万米ドルに達すると予測されています。
欧州の感染管理市場は、予測期間中に6.6%の年平均成長率(CAGR)で成長すると予測されています。市場の成長を牽引しているのは、手術件数の増加、再処理技術の進歩、食品の滅菌・消毒への関心の高まり、滅菌装置技術の進歩、そして製薬会社、医療機器メーカー、病院におけるアウトソーシングサービスの拡大です。
The European infection control market is projected to reach USD 20.58 billion by 2030 from USD 14.99 billion in 2025, at a CAGR of 6.6% during the forecast period.
The European infection control market is projected to grow at a CAGR of 6.6% during the forecast period. The growth of the market is fuelled by the growing number of surgeries, advancements in reprocessing technologies, the increasing emphasis on sterilization & disinfection of food, advancements in sterilization equipment technology, and the rising trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals.

By product & service, the cleaning & disinfection products segment accounted for the largest share of the market in 2024.
By product & service, the European infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products. In 2024, the cleaning & disinfection products segment accounted for the largest share of the European infection control market. The large share of this segment is attributed to the rising incidence of chronic diseases, stringent regulatory standards, advancements in sterilization technologies, and the favourable government support for healthcare procedures.
By end user, the hospitals & clinics segment accounted for the largest share of the market in 2024.
Based on end users, the European infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other end users. The hospitals & clinics segment accounted for the largest share of the European infection control market in 2024. The increasing number of surgical procedures and government initiatives to improve infection prevention and control have prompted greater awareness and implementation of rigorous standards.

By country, Germany is expected to dominate the European infection control market during the forecast period.
The European infection control market is segmented into 13 countries: Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the rest of Europe. Germany is projected to dominate the market during the forecast period, owing to several reinforcing factors such as strong regulatory backing through national public health initiatives and infection control programs; high healthcare expenditure; and adoption of technologically advanced infection control products, including automated disinfection systems and professional training protocols.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
- By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the European infection control market are STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), and Medline Industries, LP (US), among others.

Research Coverage
This report studies the European infection control market based on product & service, end user, and countries. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments in 13 countries.
Reasons to Buy the Report
The report will enable established and entrant/smaller firms to gauge the market’s pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights into the following points:
Analysis of key drivers (Rising prevalence of HAIs in Europe, growing number of surgeries, advancement in reprocessing technologies, rising emphasis on sterilization and disinfection of food, advancements in sterilization equipment technology, and the growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals), restraints (growing concerns about safety of reprocessed instruments, consequences associated with use of chemical disinfectants, and the high cost associated with endoscopy reprocessing coupled with limited reimbursements in emerging economies), opportunities (implementation of stringent eu guidelines and mdr compliance and growing utilization of e-beam sterilization), challenges (sterilization of advanced medical devices, alternative methods for surface disinfection, and increasing adoption of single-use medical nonwovens and devices).
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the European infection control market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the European infection control market
- Market Development: Comprehensive information on lucrative countries
- Market Diversification: Exhaustive information about new products and recent developments in the European infection control market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS & EXCLUSIONS 36
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 REGIONS COVERED 38
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 38
1.4 STAKEHOLDERS 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY DATA 42
2.1.2.1 Primary sources 42
2.1.2.2 Key industry insights 43
2.1.2.3 Key data from primary sources 43
2.1.2.4 Breakdown of primary interviews 44
2.2 MARKET SIZE ESTIMATION 44
2.2.1 BOTTOM-UP APPROACH 45
2.2.1.1 Approach 1: Company revenue estimation approach 45
2.2.1.2 Approach 2: Presentations of companies & primary interviews 46
2.2.1.3 Approach 3: Primary interviews 46
2.2.1.4 Approach 4: Growth forecast 46
2.2.1.5 CAGR projections 46
2.2.2 TOP-DOWN APPROACH 47
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 47
2.4 RESEARCH ASSUMPTIONS 49
2.4.1 STUDY-RELATED ASSUMPTIONS 49
2.4.2 GROWTH RATE ASSUMPTIONS 49
2.5 RISK ASSESSMENT 50
2.6 RESEARCH LIMITATIONS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 55
4.1 EUROPEAN INFECTION CONTROL MARKET OVERVIEW 55
4.2 EUROPEAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY (2024) 56
4.3 EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY, 2025 VS. 2030 57
4.4 EUROPEAN INFECTION CONTROL MARKET: COUNTRY MIX, 2025 VS. 2030 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
5.2.1 DRIVERS 60
5.2.1.1 Rising prevalence of HAIs 60
5.2.1.2 Increasing number of surgical procedures 61
5.2.1.3 Advancements in reprocessing technologies 62
5.2.1.4 Increasing emphasis on sterilization & disinfection of food 63
5.2.1.5 Advancements in sterilization equipment technology 63
5.2.2 RESTRAINTS 64
5.2.2.1 Growing concerns about safety of reprocessed instruments 64
5.2.2.2 Consequences associated with chemical disinfectant use 65
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursements 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Implementation of stringent EU guidelines and MDR compliance 66
5.2.3.2 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals 67
5.2.3.3 Growing utilization of E-beam sterilization 67
5.2.4 CHALLENGES 68
5.2.4.1 Sterilization of advanced medical devices 68
5.2.4.2 Alternative methods for surface disinfection 68
5.2.4.3 Increasing adoption of single-use medical devices 69
5.3 PRICING ANALYSIS 69
5.3.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER,
2022–2024 70
5.3.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022–2024 71
5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2022−2024 71
5.4 VALUE CHAIN ANALYSIS 73
5.4.1 RESEARCH & DEVELOPMENT 73
5.4.2 RAW MATERIAL SUPPLIERS 73
5.4.3 MANUFACTURING 73
5.4.4 DISTRIBUTION 73
5.4.5 MARKETING, AND SALES 73
5.4.6 POST-SALES SERVICES 74
5.5 SUPPLY CHAIN ANALYSIS 74
5.5.1 PROMINENT COMPANIES 74
5.5.2 SMALL & MEDIUM–SIZED ENTERPRISES 75
5.5.3 END USERS 75
5.6 ECOSYSTEM ANALYSIS 75
5.7 TECHNOLOGY ANALYSIS 77
5.7.1 KEY TECHNOLOGIES 77
5.7.1.1 Heat sterilization 77
5.7.1.2 Low-temperature sterilization 77
5.7.2 COMPLEMENTARY TECHNOLOGIES 78
5.7.2.1 Supercritical Co2 technology 78
5.7.2.2 Ultra-high-pressure sterilization 78
5.7.2.3 PEF sterilization 78
5.7.2.4 Plasma sterilization 78
5.8 PORTER’S FIVE FORCES ANALYSIS 79
5.8.1 THREAT OF NEW ENTRANTS 80
5.8.2 THREAT OF SUBSTITUTES 81
5.8.3 BARGAINING POWER OF SUPPLIERS 81
5.8.4 BARGAINING POWER OF BUYERS 81
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.9 REGULATORY ANALYSIS 81
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.9.2 REGULATORY LANDSCAPE 82
5.9.2.1 Europe 82
5.9.2.1.1 Germany 84
5.9.2.1.2 UK 84
5.9.2.1.3 France 84
5.9.2.1.4 Italy 85
5.9.2.1.5 Spain 85
5.10 PATENT ANALYSIS 86
5.11 TRADE ANALYSIS 87
5.11.1 IMPORT DATA FOR HS CODE 841920 88
5.11.2 EXPORT DATA FOR HS CODE 841920 88
5.12 KEY CONFERENCES & EVENTS, 2025–2026 89
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 89
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
5.14.2 BUYING CRITERIA 91
5.15 INVESTMENT & FUNDING SCENARIO 92
5.16 IMPACT OF AI/GENERATIVE AI ON EUROPEAN INFECTION CONTROL MARKET 94
5.16.1 INTRODUCTION 94
5.16.2 POTENTIAL OF AI IN EUROPEAN INFECTION CONTROL MARKET 94
5.16.3 AI USE CASES 95
5.16.4 KEY COMPANIES IMPLEMENTING AI 96
5.16.5 FUTURE OF GENERATIVE AI IN EUROPEAN INFECTION CONTROL MARKET 96
5.17 TRUMP TARIFF IMPACT ON EUROPEAN INFECTION CONTROL MARKET 96
5.17.1 INTRODUCTION 96
5.17.2 KEY TARIFF RATES 97
5.17.3 IMPACT OF TARIFFS ON PRICING 98
5.17.4 KEY IMPACT ON EUROPE 99
5.17.5 END-USER INDUSTRY IMPACT 99
6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE 101
6.1 INTRODUCTION 102
6.2 STERILIZATION PRODUCTS & SERVICES 102
6.2.1 STERILIZATION EQUIPMENT 105
6.2.1.1 Heat sterilization equipment 108
6.2.1.1.1 Moist heat sterilizers 111
6.2.1.1.1.1 Versatility across material testing to fuel market 111
6.2.1.1.2 Dry heat sterilizers 113
6.2.1.1.2.1 Increasing demand for heat-sensitive instruments to boost demand 113
6.2.1.2 Low-temperature sterilization 114
6.2.1.2.1 Hydrogen peroxide sterilization 116
6.2.1.2.1.1 Effective application across broad industries to fuel market 116
6.2.1.2.2 Ethylene oxide (EtO) sterilization 118
6.2.1.2.2.1 High penetration capabilities to fuel uptake 118
6.2.1.2.3 Formaldehyde sterilization 120
6.2.1.2.3.1 Potent antimicrobial properties to aid adoption 120
6.2.1.2.4 Other low-temperature sterilization products 121
6.2.1.3 Radiation sterilization 122
6.2.1.3.1 Utilization across pharmaceutical & biopharmaceutical sectors for vaccines & biologics to drive market 122
6.2.2 CONTRACT STERILIZATION SERVICES MARKET 124
6.2.2.1 EtO sterilization services 126
6.2.2.1.1 Expanding applications across medical device sterilization and life sciences industry to fuel market 126
6.2.2.2 Gamma sterilization services 128
6.2.2.2.1 Minimal chemical residue and ability to penetrate dense materials to fuel uptake 128
6.2.2.3 E-beam sterilization services 130
6.2.2.3.1 Rapid processing and precise control to boost market 130
6.2.2.4 Steam sterilization services 131
6.2.2.4.1 Standard method with optimal efficiency to drive market 131
6.2.2.5 Other contract sterilization services 133
6.2.3 CONSUMABLES & ACCESSORIES 135
6.2.3.1 Sterilization indicators 137
6.2.3.1.1 Chemical indicators 139
6.2.3.1.1.1 Cost-efficiency and simplicity to fuel uptake 139
6.2.3.1.2 Biological indicators 140
6.2.3.1.2.1 Consistent and precise testing features for clinical settings to boost demand 140
6.2.3.2 Sterilization pouches 142
6.2.3.2.1 Sterility maintenance with time duration to aid adoption 142
6.2.3.3 Sterilization lubricants 143
6.2.3.3.1 Prevention of equipment damage to support market growth 143
6.2.3.4 Sterilization accessories 145
6.2.3.4.1 Utilization across healthcare & pharma industries to fuel demand 145
6.3 CLEANING & DISINFECTION PRODUCTS 148
6.3.1 DISINFECTANTS 152
6.3.1.1 Disinfectants, by product type 153
6.3.1.1.1 Hand disinfectants 154
6.3.1.1.1.1 Rising awareness about health & hygiene to boost market 154
6.3.1.1.2 Surface disinfectants 156
6.3.1.1.2.1 Increasing prevalence of HAIs to fuel market 156
6.3.1.1.3 Skin disinfectants 158
6.3.1.1.3.1 Increasing incidence of infectious diseases to fuel market 158
6.3.1.1.4 Instrument disinfectants 160
6.3.1.1.4.1 Growing number of surgical procedures to boost demand 160
6.3.1.2 Disinfectants, by formulation 163
6.3.1.2.1 Liquid disinfectants 163
6.3.1.2.1.1 Effective utilization and high affordability to propel market 163
6.3.1.2.2 Disinfectant wipes 165
6.3.1.2.2.1 Easy accessibility to support market growth 165
6.3.1.2.3 Disinfectant sprays 167
6.3.1.2.3.1 Increasing usage of antimicrobial control measures to fuel demand 167
6.3.1.3 Disinfectants, by EPA classification 169
6.3.1.3.1 Low-level disinfectants 169
6.3.1.3.1.1 Effective elimination of vegetative bacteria and most viruses to boost demand 169
6.3.1.3.2 Intermediate-level disinfectants 170
6.3.1.3.2.1 Applications across dentistry and environmental monitoring to boost demand 170
6.3.1.3.3 High-level disinfectants 171
6.3.1.3.3.1 Sterilization of medical devices and semi-critical instruments across clinical settings to propel uptake 171
6.3.2 CLEANING & DISINFECTION EQUIPMENT 172
6.3.2.1 Washer disinfectors 174
6.3.2.1.1 Utilization of high-pressure water jets and detergents for disinfection to fuel market 174
6.3.2.2 Flusher disinfectors 176
6.3.2.2.1 Innovative product launches to boost demand 176
6.3.2.3 UV-ray disinfectors 178
6.3.2.3.1 Elimination of plethora of viruses, bacteria, and fungi to propel market 178
6.3.2.4 Ultrasonic cleaners 180
6.3.2.4.1 Utilization of high-frequency sound waves for microscopic dirt clearance to aid adoption 180
6.3.2.5 Other cleaning & disinfection equipment 181
6.3.3 LUBRICANTS & CLEANING SOLUTIONS 182
6.3.3.1 Utilization for disinfection of reprocessing instruments to drive market 182
6.3.4 DISINFECTION & CLEANING ACCESSORIES 184
6.3.4.1 Stringent regulatory standards to support market growth 184
6.4 PROTECTIVE BARRIERS 185
6.4.1 MEDICAL NONWOVENS 187
6.4.1.1 Face masks 189
6.4.1.1.1 Increasing prevalence of respiratory diseases to drive market 189
6.4.1.2 Surgical gowns 190
6.4.1.2.1 Growing awareness about infection control to fuel market 190
6.4.1.3 Surgical drapes 192
6.4.1.3.1 Prevention of microorganism transfer from non-sterile surfaces to fuel uptake 192
6.4.2 GLOVES 193
6.4.2.1 Growing concerns related to personnel safety to fuel uptake 193
6.4.3 COVERS & CLOSURES 194
6.4.3.1 Growing focus on food safety to fuel demand 194
6.4.4 GOGGLES 195
6.4.4.1 Increasing use of protective gear in research laboratories to support market growth 195
6.5 ENDOSCOPE REPROCESSING PRODUCTS 196
6.5.1 ENDOSCOPE REPROCESSING CONSUMABLES 199
6.5.1.1 RECURRING NATURE TO FUEL UPTAKE 199
6.5.2 ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS 201
6.5.2.1 Automated endoscope reprocessors 202
6.5.2.1.1 Enhanced efficiency of AERs compared to manual cleaning to fuel uptake 202
6.5.2.2 Endoscope tracking solutions 204
6.5.2.2.1 Ability to provide efficient traceability to fuel uptake 204
6.5.3 OTHER ENDOSCOPE REPROCESSING EQUIPMENT 205
6.6 OTHER INFECTION CONTROL PRODUCTS 207
7 INFECTION CONTROL MARKET, BY END USER 209
7.1 INTRODUCTION 210
7.2 HOSPITALS & CLINICS 210
7.2.1 STRINGENT CLEANLINESS PROTOCOLS FOR RESTRICTION OF HAIS TO PROPEL MARKET 210
7.3 MEDICAL DEVICE COMPANIES 213
7.3.1 RISING TECHNOLOGICAL INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE MARKET 213
7.4 PHARMACEUTICAL COMPANIES 215
7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET 215
7.5 LIFE SCIENCES INDUSTRY 216
7.5.1 INCREASING FOCUS ON CLINICAL RESEARCH INITIATIVES TO FUEL MARKET 216
7.6 FOOD INDUSTRY 218
7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO SUPPORT MARKET GROWTH 218
7.7 OTHER END USERS 219
8 EUROPEAN INFECTION CONTROL MARKET, BY REGION 221
8.1 INTRODUCTION 222
8.2 EUROPE 223
8.2.1 MACROECONOMIC OUTLOOK FOR EUROPE 225
8.2.2 GERMANY 235
8.2.2.1 Growing adoption of hospital disinfection & surveillance systems to drive market 235
8.2.3 UK 244
8.2.3.1 High prevalence of HAIS to drive market 244
8.2.4 FRANCE 254
8.2.4.1 Stringent regulatory guidelines for infection control product commercialization to fuel uptake 254
8.2.5 ITALY 264
8.2.5.1 Increasing establishment of long-term care facilities to boost demand 264
8.2.6 SPAIN 273
8.2.6.1 Increasing prevalence of infectious diseases to fuel market 273
8.2.7 SWITZERLAND 283
8.2.7.1 Heightened burden of CAUTI to drive market 283
8.2.8 POLAND 292
8.2.8.1 Growing volume of surgeries to fuel uptake 292
8.2.9 AUSTRIA 301
8.2.9.1 Rising incidence of notifiable infectious diseases to drive market 301
8.2.10 ROMANIA 311
8.2.10.1 Efficient implementation of disease surveillance systems to boost demand 311
8.2.11 CZECH REPUBLIC 321
8.2.11.1 Growing number of surgical & dental procedures to fuel market 321
8.2.12 SLOVAKIA 330
8.2.12.1 Improvements in healthcare infrastructure to boost demand 330
8.2.13 PORTUGAL 339
8.2.13.1 Rising prevalence of chronic conditions to drive market 339
8.2.14 REST OF EUROPE 348
9 COMPETITIVE LANDSCAPE 359
9.1 INTRODUCTION 359
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 359
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET 359
9.3 REVENUE ANALYSIS, 2020−2024 360
9.4 MARKET SHARE ANALYSIS, 2024 361
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 364
9.5.1 STARS 364
9.5.2 EMERGING LEADERS 364
9.5.3 PERVASIVE PLAYERS 364
9.5.4 PARTICIPANTS 364
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 366
9.5.5.1 Company footprint 366
9.5.5.2 Region footprint 367
9.5.5.3 Product & service footprint 368
9.5.5.4 End-user footprint 369
9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 370
9.6.1 PROGRESSIVE COMPANIES 370
9.6.2 RESPONSIVE COMPANIES 370
9.6.3 DYNAMIC COMPANIES 370
9.6.4 STARTING BLOCKS 370
9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 372
9.6.5.1 Detailed list of key startup/SME players 372
9.6.5.2 Competitive benchmarking of key startups/SMEs 373
9.7 COMPANY VALUATION AND FINANCIAL METRICS 374
9.7.1 FINANCIAL METRICS 374
9.7.2 COMPANY VALUATION 374
9.8 BRAND/PRODUCT COMPARISON 375
9.9 COMPETITIVE SCENARIO 376
9.9.1 PRODUCT LAUNCHES 376
9.9.2 DEALS 377
9.9.3 EXPANSIONS 378
10 COMPANY PROFILES 379
10.1 KEY PLAYERS 379
10.1.1 STERIS 379
10.1.1.1 Business overview 379
10.1.1.2 Products/Services offered 380
10.1.1.3 Recent developments 384
10.1.1.3.1 Deals 384
10.1.1.4 MnM view 384
10.1.1.4.1 Key strengths 384
10.1.1.4.2 Strategic choices 385
10.1.1.4.3 Weaknesses & competitive threats 385
10.1.2 RECKITT BENCKISER 386
10.1.2.1 Business overview 386
10.1.2.2 Products/Services offered 387
10.1.2.3 Recent developments 388
10.1.2.3.1 Deals 388
10.1.2.4 MnM view 388
10.1.2.4.1 Key strengths 388
10.1.2.4.2 Strategic choices 389
10.1.2.4.3 Weaknesses & competitive threats 389
10.1.3 PAUL HARTMANN 390
10.1.3.1 Business overview 390
10.1.3.2 Products/Services offered 391
10.1.3.3 MnM view 392
10.1.3.3.1 Key strengths 392
10.1.3.3.2 Strategic choices 392
10.1.3.3.3 Weaknesses & competitive threats 392
10.1.4 ECOLAB, INC. 393
10.1.4.1 Business overview 393
10.1.4.2 Products/Services offered 394
10.1.4.3 Recent developments 401
10.1.4.3.1 Deals 401
10.1.4.3.2 Product/Service launches 401
10.1.4.4 MnM view 401
10.1.4.4.1 Key strengths 401
10.1.4.4.2 Strategic choices 402
10.1.4.4.3 Weaknesses & competitive threats 402
10.1.5 B. BRAUN SE 403
10.1.5.1 Business overview 403
10.1.5.2 Products/Services offered 404
10.1.5.3 Recent developments 405
10.1.5.3.1 Other developments 405
10.1.5.4 MnM view 405
10.1.5.4.1 Key strengths 405
10.1.5.4.2 Strategic choices 406
10.1.5.4.3 Weaknesses & competitive threats 406
10.1.6 GETINGE AB 407
10.1.6.1 Business overview 407
10.1.6.2 Products/Services offered 408
10.1.6.3 Recent developments 413
10.1.6.3.1 Deals 413
10.1.6.3.2 Product/Service launches 414
10.1.7 ADVANCED STERILIZATION PRODUCTS (SUBSIDIARY OF FORTIVE CORPORATION) 415
10.1.7.1 Business overview 415
10.1.7.2 Products/Services offered 416
10.1.8 SOLVENTUM CORPORATION 418
10.1.8.1 Business overview 418
10.1.8.2 Products/Services offered 419
10.1.9 KIMBERLY-CLARK CORPORATION 424
10.1.9.1 Business overview 424
10.1.9.2 Products/Services offered 425
10.1.10 OLYMPUS CORPORATION 427
10.1.10.1 Business overview 427
10.1.10.2 Products/Services offered 428
10.1.10.3 Recent developments 429
10.1.10.3.1 Deals 429
10.1.10.3.2 Product/Service launches 430
10.1.10.3.3 Other developments 431
10.1.11 CARDINAL HEALTH 432
10.1.11.1 Business overview 432
10.1.11.2 Products/Services offered 433
10.1.11.3 Recent developments 435
10.1.11.3.1 Other developments 435
10.1.12 THE MIELE GROUP (JOINT VENTURE WITH STEELCOBELIMED AG) 436
10.1.12.1 Business overview 436
10.1.12.2 Products/Services offered 436
10.1.12.3 Recent developments 443
10.1.12.3.1 Deals 443
10.1.13 MMM GROUP 444
10.1.13.1 Business overview 444
10.1.13.2 Products/Services offered 444
10.1.13.3 Recent developments 446
10.1.13.3.1 Product/Service launches 446
10.1.14 MATACHANA GROUP 447
10.1.14.1 Business overview 447
10.1.14.2 Products/Services offered 447
10.1.15 MEDLINE INDUSTRIES, LP 450
10.1.15.1 Business overview 450
10.1.15.2 Products/Services offered 450
10.2 OTHER PLAYERS 452
10.2.1 CONTEC, INC. 452
10.2.2 DE LAMA SPA 455
10.2.3 SYSTEC GMBH & CO. KG 456
10.2.4 PAL INTERNATIONAL 457
10.2.5 MELAG MEDIZINTECHNIK GMBH & CO. KG 459
10.2.6 MEDALKAN 460
10.2.7 C.B.M. S.R.L. MEDICAL EQUIPMENT 462
10.2.8 DR. SCHUMACHER GMBH 463
10.2.9 ACTO GMBH 464
10.2.10 ULTRAWAVE 465
11 APPENDIX 466
11.1 DISCUSSION GUIDE 466
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 473
11.3 CUSTOMIZATION OPTIONS 475
11.4 RELATED REPORTS 475
11.5 AUTHOR DETAILS 476
LIST OF TABLES
TABLE 1 EUROPEAN INFECTION CONTROL MARKET: INCLUSIONS & EXCLUSIONS 36
TABLE 2 EUROPEAN INFECTION CONTROL MARKET: RISK ASSESSMENT ANALYSIS 50
TABLE 3 EUROPE: PREVALENCE OF HAIS IN ACUTE CARE HOSPITALS, BY HAI TYPE,
2022–2023 60
TABLE 4 GERMANY: SURGERY TYPES FOR INPATIENT HOSPITAL VISITS, 2023 62
TABLE 5 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS,
BY KEY PLAYER, 2022–2024 (USD) 70
TABLE 6 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS,
BY REGION, 2022–2024 (USD) 71
TABLE 7 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS,
BY TYPE, 2022–2024 (USD) 72
TABLE 8 EUROPEAN INFECTION CONTROL MARKET: ROLE IN ECOSYSTEM 76
TABLE 9 EUROPEAN INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS 79
TABLE 10 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 11 STANDARDS RELATED TO DESIGNATING MEDICAL DEVICES AS STERILE 83
TABLE 12 STERILIZATION STANDARDS IN EUROPEAN UNION 83
TABLE 13 LIST OF PATENTS IN EUROPEAN INFECTION CONTROL MARKET, 2022–2024 87
TABLE 14 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2019–2024 (USD MILLION) 88
TABLE 15 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2019–2024 (USD MILLION) 88
TABLE 16 EUROPEAN INFECTION CONTROL MARKET: KEY CONFERENCES & EVENTS, 2025−2026 89
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP
THREE PRODUCTS (%) 91
TABLE 18 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS 92
TABLE 19 ADOPTION OF AI BY KEY INDUSTRY PLAYERS 96
TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES 97
TABLE 21 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 102
TABLE 22 KEY PLAYERS PROVIDING STERILIZATION PRODUCTS 103
TABLE 23 STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 104
TABLE 24 EUROPE: STERILIZATION PRODUCTS & SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 25 KEY PLAYERS PROVIDING STERILIZATION EQUIPMENT 106
TABLE 26 STERILIZATION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 107
TABLE 27 EUROPE: STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 28 KEY PLAYERS PROVIDING HEAT STERILIZATION EQUIPMENT 109
TABLE 29 HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 110
TABLE 30 EUROPE: HEAT STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 31 MOIST HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 111
TABLE 32 EUROPE: MOIST HEAT STERILIZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 33 DRY HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 113
TABLE 34 EUROPE: DRY HEAT STERILIZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 35 LOW-TEMPERATURE STERILIZERS OFFERED BY KEY MARKET PLAYERS 115
TABLE 36 LOW-TEMPERATURE STERILIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 115
TABLE 37 EUROPE: LOW-TEMPERATURE STERILIZATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 38 HYDROGEN PEROXIDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 117
TABLE 39 GLOBAL INSTALLED UNITS OF LOW-TEMPERATURE HYDROGEN PEROXIDE GAS PLASMA STERILIZERS, 2023–2030 (UNITS) 117
TABLE 40 EUROPE: HYDROGEN PEROXIDE STERILIZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 41 ETO STERILIZERS OFFERED BY KEY MARKET PLAYERS 119
TABLE 42 EUROPE: ETO STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 43 FORMALDEHYDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 120
TABLE 44 EUROPE: FORMALDEHYDE STERILIZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 45 EUROPE: OTHER LOW-TEMPERATURE STERILIZATION PRODUCTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 46 RADIATION STERILIZERS OFFERED BY KEY MARKET PLAYERS 123
TABLE 47 EUROPE: RADIATION STERILIZATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 48 CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 125
TABLE 49 CONTRACT STERILIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 125
TABLE 50 EUROPE: CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 51 ETO STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 127
TABLE 52 EUROPE: ETO STERILIZATION SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 53 GAMMA STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 129
TABLE 54 EUROPE: GAMMA STERILIZATION SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 129
TABLE 55 E-BEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 130
TABLE 56 EUROPE: E-BEAM STERILIZATION SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 57 STEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 132
TABLE 58 EUROPE: STEAM STERILIZATION SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 133
TABLE 59 OTHER CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 134
TABLE 60 EUROPE: OTHER CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 61 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 62 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 63 STERILIZATION INDICATORS OFFERED BY KEY MARKET PLAYERS 137
TABLE 64 STERILIZATION INDICATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138
TABLE 65 EUROPE: STERILIZATION INDICATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 138
TABLE 66 CHEMICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 139
TABLE 67 EUROPE: CHEMICAL INDICATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 140
TABLE 68 BIOLOGICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 141
TABLE 69 EUROPE: BIOLOGICAL INDICATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 141
TABLE 70 STERILIZATION POUCHES OFFERED BY KEY MARKET PLAYERS 142
TABLE 71 EUROPE: STERILIZATION POUCHES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 72 STERILIZATION LUBRICANTS OFFERED BY KEY MARKET PLAYERS 144
TABLE 73 EUROPE: STERILIZATION LUBRICANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 74 STERILIZATION ACCESSORIES OFFERED BY KEY MARKET PLAYERS 145
TABLE 75 EUROPE: STERILIZATION ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 147
TABLE 76 CLEANING & DISINFECTION PRODUCTS OFFERED BY KEY MARKET PLAYERS 148
TABLE 77 CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 78 EUROPE: CLEANING & DISINFECTION PRODUCTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 79 COMMON DISINFECTANTS USED IN INDUSTRIAL SETTINGS 152
TABLE 80 EUROPE: DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 81 DISINFECTANTS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 154
TABLE 82 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 155
TABLE 83 EUROPE: HAND DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 155
TABLE 84 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 156
TABLE 85 EUROPE: SURFACE DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 157
TABLE 86 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 158
TABLE 87 EUROPE: SKIN DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 160
TABLE 88 INSTRUMENT DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 161
TABLE 89 EUROPE: INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 162
TABLE 90 DISINFECTANTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 163
TABLE 91 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 164
TABLE 92 EUROPE: LIQUID DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 165
TABLE 93 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS 166
TABLE 94 EUROPE: DISINFECTANT WIPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 167
TABLE 95 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS 168
TABLE 96 EUROPE: DISINFECTANT SPRAYS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 168
TABLE 97 DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2023–2030 (USD MILLION) 169
TABLE 98 EUROPE: LOW-LEVEL DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 170
TABLE 99 EUROPE: INTERMEDIATE-LEVEL DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 171
TABLE 100 EUROPE: HIGH-LEVEL DISINFECTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 172
TABLE 101 CLEANING & DISINFECTION EQUIPMENT OFFERED BY KEY MARKET PLAYERS 173
TABLE 102 CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 103 EUROPE: CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 174
TABLE 104 WASHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 175
TABLE 105 EUROPE: WASHER DISINFECTORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 176
TABLE 106 FLUSHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 177
TABLE 107 EUROPE: FLUSHER DISINFECTORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 178
TABLE 108 UV-RAY DISINFECTORS OFFERED BY KEY MARKET PLAYERS 179
TABLE 109 EUROPE: UV-RAY DISINFECTORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 180
TABLE 110 EUROPE: ULTRASONIC CLEANERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 181
TABLE 111 EUROPE: OTHER CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 112 LUBRICANTS & CLEANING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 183
TABLE 113 EUROPE: LUBRICANTS & CLEANING SOLUTIONS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 184
TABLE 114 EUROPE: DISINFECTION & CLEANING ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 115 PROTECTIVE BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 116 EUROPE: PROTECTIVE BARRIERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 186
TABLE 117 MEDICAL NONWOVENS OFFERED BY KEY MARKET PLAYERS 187
TABLE 118 MEDICAL NONWOVENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 119 EUROPE: MEDICAL NONWOVENS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 188
TABLE 120 EUROPE: FACE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 121 LEVELS OF SURGICAL GOWNS 190
TABLE 122 EUROPE: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191
TABLE 123 EUROPE: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 124 EUROPE: GLOVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 125 EUROPE: COVERS & CLOSURES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 195
TABLE 126 EUROPE: GOGGLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 196
TABLE 127 ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS 197
TABLE 128 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 198
TABLE 129 EUROPE: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 198
TABLE 130 ENDOSCOPE REPROCESSING CONSUMABLES OFFERED BY KEY MARKET PLAYERS 199
TABLE 131 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200
TABLE 132 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 133 EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 202
TABLE 134 AUTOMATED ENDOSCOPE REPROCESSORS OFFERED BY KEY MARKET PLAYERS 203
TABLE 135 EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204
TABLE 136 ENDOSCOPE TRACKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 205
TABLE 137 EUROPE: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 205
TABLE 138 OTHER ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY
KEY MARKET PLAYERS 206
TABLE 139 EUROPE: OTHER ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207
TABLE 140 EUROPE: OTHER INFECTION CONTROL PRODUCTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 208
TABLE 141 INFECTION CONTROL MARKET, BY END USER, 2023–2030 (USD MILLION) 210
TABLE 142 EXAMPLES OF CRITICAL-ACCESS HOSPITALS IMPLEMENTING
EVIDENCE-BASED PROGRAMS FOR HAIS 211
TABLE 143 EUROPE: INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023–2030 (USD MILLION) 213
TABLE 144 EUROPE: INFECTION CONTROL MARKET FOR MEDICAL DEVICE COMPANIES,
BY COUNTRY, 2023–2030 (USD MILLION) 214
TABLE 145 DIFFERENT METHODS OF STERILIZATION IN PHARMACEUTICAL COMPANIES 215
TABLE 146 EUROPE: INFECTION CONTROL MARKET FOR PHARMACEUTICAL COMPANIES,
BY COUNTRY, 2023–2030 (USD MILLION) 216
TABLE 147 EUROPE: INFECTION CONTROL MARKET FOR LIFE SCIENCE INDUSTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 217
TABLE 148 EUROPE: INFECTION CONTROL MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 219
TABLE 149 EUROPE: INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 220
TABLE 150 EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 222
TABLE 151 EUROPE: KEY MACROECONOMIC INDICATORS 225
TABLE 152 EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 226
TABLE 153 EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 154 EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 155 EUROPE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 156 EUROPE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 157 EUROPE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 158 EUROPE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 159 EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 160 EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 161 EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 230
TABLE 162 EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 231
TABLE 163 EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 231
TABLE 164 EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 165 EUROPE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 166 EUROPE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 167 EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 168 EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 169 EUROPE: INFECTION CONTROL MARKET, BY END USER,
2023–2030 (USD MILLION) 234
TABLE 170 GERMANY: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 236
TABLE 171 GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 172 GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 173 GERMANY: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 174 GERMANY: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 175 GERMANY: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 176 GERMANY: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 177 GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 178 GERMANY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 179 GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 240
TABLE 180 GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 241
TABLE 181 GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 241
TABLE 182 GERMANY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 183 GERMANY: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 184 GERMANY: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 185 GERMANY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 186 GERMANY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 187 GERMANY: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 244
TABLE 188 UK: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 246
TABLE 189 UK: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES,
BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 190 UK: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 191 UK: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 192 UK: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 193 UK: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES,
BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 194 UK: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 195 UK: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 196 UK: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS,
BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 197 UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 250
TABLE 198 UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 251
TABLE 199 UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 251
TABLE 200 UK: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 201 UK: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 202 UK: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE,
2023–2030 (USD MILLION) 253
TABLE 203 UK: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 204 UK: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 205 UK: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 254
TABLE 206 FRANCE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 256
TABLE 207 FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 208 FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 209 FRANCE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 210 FRANCE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 211 FRANCE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 212 FRANCE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 213 FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 214 FRANCE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 215 FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 260
TABLE 216 FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 261
TABLE 217 FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 261
TABLE 218 FRANCE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 219 FRANCE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 220 FRANCE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 221 FRANCE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 222 FRANCE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 223 FRANCE: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 264
TABLE 224 ITALY: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 265
TABLE 225 ITALY: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 226 ITALY: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 227 ITALY: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 228 ITALY: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 229 ITALY: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES,
BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 230 ITALY: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 231 ITALY: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 232 ITALY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 233 ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 269
TABLE 234 ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 270
TABLE 235 ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 270
TABLE 236 ITALY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 237 ITALY: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE,
2023–2030 (USD MILLION) 271
TABLE 238 ITALY: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE,
2023–2030 (USD MILLION) 272
TABLE 239 ITALY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 240 ITALY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 241 ITALY: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 273
TABLE 242 SPAIN: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 275
TABLE 243 SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 244 SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 245 SPAIN: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 246 SPAIN: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 247 SPAIN: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 248 SPAIN: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 249 SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 250 SPAIN: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 251 SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 279
TABLE 252 SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 280
TABLE 253 SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 280
TABLE 254 SPAIN: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 255 SPAIN: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 256 SPAIN: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 282
TABLE 257 SPAIN: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 282
TABLE 258 SPAIN: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 259 SPAIN: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 283
TABLE 260 SWITZERLAND: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 284
TABLE 261 SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 262 SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 263 SWITZERLAND: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 264 SWITZERLAND: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 265 SWITZERLAND: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 266 SWITZERLAND: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 267 SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 268 SWITZERLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 269 SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 288
TABLE 270 SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY FORMULATION TYPE, 2023–2030 (USD MILLION) 289
TABLE 271 SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 289
TABLE 272 SWITZERLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 273 SWITZERLAND: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,
BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 274 SWITZERLAND: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,
BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 275 SWITZERLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 276 SWITZERLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 277 SWITZERLAND: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 292
TABLE 278 POLAND: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 293
TABLE 279 POLAND: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 280 POLAND: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 281 POLAND: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 282 POLAND: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 295
TABLE 283 POLAND: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 295
TABLE 284 POLAND: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 285 POLAND: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 286 POLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 297
TABLE 287 POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 297
TABLE 288 POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 298
TABLE 289 POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 298
TABLE 290 POLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 291 POLAND: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,
BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 292 POLAND: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,
BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 293 POLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 294 POLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 295 POLAND: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 301
TABLE 296 AUSTRIA: REPORTED CASES OF NOTIFIABLE DISEASES 302
TABLE 297 AUSTRIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 303
TABLE 298 AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 303
TABLE 299 AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 304
TABLE 300 AUSTRIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 304
TABLE 301 AUSTRIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 302 AUSTRIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 303 AUSTRIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 304 AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 305 AUSTRIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 306 AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 307
TABLE 307 AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 308
TABLE 308 AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 308
TABLE 309 AUSTRIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 309
TABLE 310 AUSTRIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 309
TABLE 311 AUSTRIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 310
TABLE 312 AUSTRIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 310
TABLE 313 AUSTRIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 311
TABLE 314 AUSTRIA: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 311
TABLE 315 ROMANIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 313
TABLE 316 ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 313
TABLE 317 ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 314
TABLE 318 ROMANIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 314
TABLE 319 ROMANIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 315
TABLE 320 ROMANIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 315
TABLE 321 ROMANIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,
BY TYPE, 2023–2030 (USD MILLION) 316
TABLE 322 ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 316
TABLE 323 ROMANIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 317
TABLE 324 ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 317
TABLE 325 ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 318
TABLE 326 ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 318
TABLE 327 ROMANIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 319
TABLE 328 ROMANIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 319
TABLE 329 ROMANIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 320
TABLE 330 ROMANIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 320
TABLE 331 ROMANIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 321
TABLE 332 ROMANIA: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 321
TABLE 333 CZECH REPUBLIC: NUMBER OF INDEPENDENT SURGERIES (2019─2023) 322
TABLE 334 CZECH REPUBLIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 322
TABLE 335 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 336 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 337 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 338 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 324
TABLE 339 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 324
TABLE 340 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 325
TABLE 341 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 325
TABLE 342 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 326
TABLE 343 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 326
TABLE 344 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY FORMULATION TYPE, 2023–2030 (USD MILLION) 327
TABLE 345 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 327
TABLE 346 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 328
TABLE 347 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,
BY TYPE, 2023–2030 (USD MILLION) 328
TABLE 348 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,
BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 349 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 350 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 330
TABLE 351 CZECH REPUBLIC: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 330
TABLE 352 SLOVAKIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 331
TABLE 353 SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 331
TABLE 354 SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 332
TABLE 355 SLOVAKIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 332
TABLE 356 SLOVAKIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 333
TABLE 357 SLOVAKIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 333
TABLE 358 SLOVAKIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 334
TABLE 359 SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 334
TABLE 360 SLOVAKIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 335
TABLE 361 SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 335
TABLE 362 SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 336
TABLE 363 SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 336
TABLE 364 SLOVAKIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 365 SLOVAKIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 366 SLOVAKIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 338
TABLE 367 SLOVAKIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 338
TABLE 368 SLOVAKIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 339
TABLE 369 SLOVAKIA: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 339
TABLE 370 PORTUGAL: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 340
TABLE 371 PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 341
TABLE 372 PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,
BY TYPE, 2023–2030 (USD MILLION) 341
TABLE 373 PORTUGAL: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 341
TABLE 374 PORTUGAL: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 342
TABLE 375 PORTUGAL: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 342
TABLE 376 PORTUGAL: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 343
TABLE 377 PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,
BY TYPE, 2023–2030 (USD MILLION) 343
TABLE 378 PORTUGAL: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 344
TABLE 379 PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 344
TABLE 380 PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 345
TABLE 381 PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 345
TABLE 382 PORTUGAL: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 346
TABLE 383 PORTUGAL: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 346
TABLE 384 PORTUGAL: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 347
TABLE 385 PORTUGAL: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 347
TABLE 386 PORTUGAL: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 348
TABLE 387 PORTUGAL: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 348
TABLE 388 REST OF EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 350
TABLE 389 REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 350
TABLE 390 REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 351
TABLE 391 REST OF EUROPE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 351
TABLE 392 REST OF EUROPE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 352
TABLE 393 REST OF EUROPE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 352
TABLE 394 REST OF EUROPE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 353
TABLE 395 REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 353
TABLE 396 REST OF EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 354
TABLE 397 REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 354
TABLE 398 REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY FORMULATION TYPE, 2023–2030 (USD MILLION) 355
TABLE 399 REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 355
TABLE 400 REST OF EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 356
TABLE 401 REST OF EUROPE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,
BY TYPE, 2023–2030 (USD MILLION) 356
TABLE 402 REST OF EUROPE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,
BY TYPE, 2023–2030 (USD MILLION) 357
TABLE 403 REST OF EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 357
TABLE 404 REST OF EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 358
TABLE 405 REST OF EUROPE: INFECTION CONTROL MARKET, BY END USERS,
2023–2030 (USD MILLION) 358
TABLE 406 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
EUROPEAN INFECTION CONTROL MARKET 359
TABLE 407 EUROPEAN INFECTION CONTROL MARKET: DEGREE OF COMPETITION 362
TABLE 408 EUROPEAN INFECTION CONTROL MARKET: REGION FOOTPRINT 367
TABLE 409 EUROPEAN INFECTION CONTROL MARKET: PRODUCT & SERVICE FOOTPRINT 368
TABLE 410 EUROPEAN INFECTION CONTROL MARKET: END-USER FOOTPRINT 369
TABLE 411 EUROPEAN INFECTION CONTROL MARKET: DETAILED LIST OF
KEY STARTUP/ SME PLAYERS 372
TABLE 412 EUROPEAN INFECTION CONTROL MARKET: COMPETITIVE
BENCHMARKING OF STARTUPS/SMES 373
TABLE 413 EUROPEAN INFECTION CONTROL MARKET: PRODUCT/SERVICE
LAUNCHES, JANUARY 2022–JUNE 2025 376
TABLE 414 EUROPEAN INFECTION CONTROL MARKET: DEALS, JANUARY 2022–JUNE 2025 377
TABLE 415 EUROPEAN INFECTION CONTROL MARKET: EXPANSIONS,
JANUARY 2022–JUNE 2025 378
TABLE 416 STERIS: COMPANY OVERVIEW 379
TABLE 417 STERIS PLC: PRODUCTS/SERVICES OFFERED 380
TABLE 418 STERIS PLC: DEALS, JANUARY 2022–JUNE 2025 384
TABLE 419 RECKITT BENCKISER: COMPANY OVERVIEW 386
TABLE 420 RECKITT BENCKISER: PRODUCTS/SERVICES OFFERED 387
TABLE 421 RECKITT BENCKISER: DEALS, JANUARY 2022– JUNE 2025 388
TABLE 422 PAUL HARTMANN: COMPANY OVERVIEW 390
TABLE 423 PAUL HARTMANN: PRODUCTS/SERVICES OFFERED 391
TABLE 424 ECOLAB, INC.: COMPANY OVERVIEW 393
TABLE 425 ECOLAB, INC.: PRODUCTS/SERVICES OFFERED 394
TABLE 426 ECOLAB, INC.: DEALS, JANUARY 2021–JUNE 2025 401
TABLE 427 ECOLAB, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 401
TABLE 428 B. BRAUN SE: COMPANY OVERVIEW 403
TABLE 429 B. BRAUN SE: PRODUCTS/SERVICES OFFERED 404
TABLE 430 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 405
TABLE 431 GETINGE AB: COMPANY OVERVIEW 407
TABLE 432 GETINGE AB: PRODUCTS/SERVICES OFFERED 408
TABLE 433 GETINGE AB: DEALS, JANUARY 2022–JUNE 2025 413
TABLE 434 GETINGE AB: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 414
TABLE 435 FORTIVE CORPORATION: COMPANY OVERVIEW 415
TABLE 436 FORTIVE CORPORATION: PRODUCTS/SERVICES OFFERED 416
TABLE 437 SOLVENTUM CORPORATION: COMPANY OVERVIEW 418
TABLE 438 SOLVENTUM CORPORATION: PRODUCTS/SERVICES OFFERED 419
TABLE 439 KIMBERLY CLARK PROFESSIONAL: COMPANY OVERVIEW 424
TABLE 440 KIMBERLY-CLARK CORPORATION: PRODUCTS/SERVICES OFFERED 425
TABLE 441 OLYMPUS CORPORATION: COMPANY OVERVIEW 427
TABLE 442 OLYMPUS CORPORATION: PRODUCTS/SERVICES OFFERED 428
TABLE 443 OLYMPUS CORPORATION: DEALS, JANUARY 2022–JUNE 2025 429
TABLE 444 OLYMPUS CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2022–JUNE 2025 430
TABLE 445 OLYMPUS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 431
TABLE 446 CARDINAL HEALTH: COMPANY OVERVIEW 432
TABLE 447 CARDINAL HEALTH: PRODUCTS/SERVICES OFFERED 433
TABLE 448 CARDINAL HEALTH: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 435
TABLE 449 THE MIELE GROUP: COMPANY OVERVIEW 436
TABLE 450 THE MIELE GROUP: PRODUCTS/SERVICES OFFERED 436
TABLE 451 THE MIELE GROUP: DEALS, JANUARY 2022–JUNE 2025 443
TABLE 452 MMM GROUP: COMPANY OVERVIEW 444
TABLE 453 MMM GROUP: PRODUCTS/SERVICES OFFERED 444
TABLE 454 MMM GROUP: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 446
TABLE 455 MATACHANA GROUP: COMPANY OVERVIEW 447
TABLE 456 MATACHANA GROUP: PRODUCTS/SERVICES OFFERED 447
TABLE 457 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 450
TABLE 458 MEDLINE INDUSTRIES, LP: PRODUCTS/SERVICES OFFERED 450
TABLE 459 CONTEC, INC.: COMPANY OVERVIEW 452
TABLE 460 DE LAMA SPA: COMPANY OVERVIEW 455
TABLE 461 SYSTEC GMBH & CO. KG: COMPANY OVERVIEW 456
TABLE 462 PAL INTERNATIONAL: COMPANY OVERVIEW 457
TABLE 463 MELAG MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 459
TABLE 464 MEDALKAN: COMPANY OVERVIEW 460
TABLE 465 C.B.M. S.R.L. MEDICAL EQUIPMENT: COMPANY OVERVIEW 462
TABLE 466 DR. SCHUMACHER GMBH: COMPANY OVERVIEW 463
TABLE 467 ACTO GMBH: COMPANY OVERVIEW 464
TABLE 468 ULTRAWAVE: COMPANY OVERVIEW 465
LIST OF FIGURES
FIGURE 1 MARKET SEGMENTATION 37
FIGURE 2 EUROPEAN INFECTION CONTROL MARKET: RESEARCH DESIGN 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE AND DESIGNATION 44
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 45
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46
FIGURE 6 EUROPEAN INFECTION CONTROL MARKET: TOP-DOWN APPROACH 47
FIGURE 7 DATA TRIANGULATION METHODOLOGY 48
FIGURE 8 EUROPEAN INFECTION CONTROL MARKET: IMPACT ASSESSMENT ANALYSIS 49
FIGURE 9 EUROPEAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,
2025 VS. 2030 (USD MILLION) 51
FIGURE 10 EUROPEAN INFECTION CONTROL MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 52
FIGURE 11 EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY,
2025 VS. 2030 (USD MILLION) 53
FIGURE 12 RISING INCIDENCE OF HAIS AND STRINGENT IMPLEMENTATION OF INFECTION CONTROL PROTOCOL MEASURES TO PROPEL MARKET 55
FIGURE 13 CLEANING & DISINFECTION PRODUCTS & SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2024 56
FIGURE 14 GERMANY TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 57
FIGURE 15 GERMANY TO DOMINATE MARKET DURING FORECAST PERIOD 58
FIGURE 16 EUROPEAN INFECTION CONTROL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
FIGURE 17 EUROPEAN INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS 74
FIGURE 18 EUROPEAN INFECTION CONTROL MARKET: SUPPLY CHAIN ANALYSIS 75
FIGURE 19 EUROPEAN INFECTION CONTROL MARKET: ECOSYSTEM MAPPING 76
FIGURE 20 EUROPEAN INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS 80
FIGURE 21 EUROPEAN INFECTION CONTROL MARKET: PATENT ANALYSIS, 2014–2024 86
FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS 91
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS 92
FIGURE 25 EUROPEAN INFECTION CONTROL MARKET: INVESTMENT &
FUNDING ACTIVITIES, 2022−2025 93
FIGURE 26 AI USE CASES 95
FIGURE 27 EUROPE: EUROPEAN INFECTION CONTROL MARKET SNAPSHOT 224
FIGURE 28 ROMANIA: POPULATION AGED 65 & ABOVE (2020−2024) 312
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET, 2020–2024 361
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET (2024) 362
FIGURE 31 EUROPEAN INFECTION CONTROL MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 365
FIGURE 32 EUROPEAN INFECTION CONTROL MARKET: COMPANY FOOTPRINT 366
FIGURE 33 EUROPEAN INFECTION CONTROL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 371
FIGURE 34 EV/EBITDA OF KEY VENDORS, 2025 374
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS, 2025 374
FIGURE 36 EUROPEAN INFECTION CONTROL MARKET: BRAND/PRODUCT COMPARISON 375
FIGURE 37 STERIS PLC: COMPANY SNAPSHOT (2024) 380
FIGURE 38 RECKITT BENCKISER: COMPANY SNAPSHOT (2024) 387
FIGURE 39 PAUL HARTMANN: COMPANY SNAPSHOT (2024) 391
FIGURE 40 ECOLAB, INC.: COMPANY SNAPSHOT (2024) 394
FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2024) 404
FIGURE 42 GETINGE AB: COMPANY SNAPSHOT (2024) 408
FIGURE 43 FORTIVE CORPORATION: COMPANY SNAPSHOT (2024) 416
FIGURE 44 SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024) 419
FIGURE 45 KIMBERLY CLARK CORPORATION: COMPANY SNAPSHOT (2024) 425
FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 428
FIGURE 47 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 433
MarketsandMarkets(マーケッツアンドマーケッツ)は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11